Chapter 15: The Rakshas Move

The attack came not as: violence but as: business.

A pharmaceutical company — Zenith Cosmeceuticals, headquartered in Gurgaon, with offices in seventeen countries and a market capitalisation of forty-two thousand crores — approached Dr. Subramaniam with: an offer. Not a hostile offer. A polite offer. The offer that Indian corporate power made when it wanted to: acquire. The offer wrapped in: handshakes and: NDAs and: the specific language of partnership that actually meant: absorption.

"We'd like to license the golden-ratio technology," said the Zenith representative. His name was Vikram Malhotra. He wore a suit that cost more than Harini's annual school fees. He sat in Dr. Subramaniam's lab on a chair designed for: students and managed to make it look like: a throne.

"License," said Dr. Subramaniam.

"Exclusive license. We handle manufacturing, distribution, regulatory compliance. You handle research. We pay: royalties. Everyone wins."

"What royalties?" asked Jai. Who had not been invited to the meeting but who had: appeared. The way Jai appeared at every meeting that involved: money.

"Standard industry rates. Eight per cent of net revenue."

"Eight per cent," Jai repeated. The repetition that meant: calculation. "Your company made fourteen thousand crores in revenue last year. If this product captures even five per cent of the global cosmetics market — which is a nine lakh crore market — that's forty-five thousand crores. Eight per cent of that is: three thousand six hundred crores. For us. And for you: forty-one thousand four hundred crores. That's: not partnership. That's: theft."

Vikram Malhotra looked at the teenager who had just performed revenue arithmetic that would have taken his CFO: a spreadsheet. The specific look of a corporate executive encountering: competence in an unexpected: package.

"The percentage is negotiable," said Vikram.

"The percentage is: irrelevant," said Harini. Who had been silent. Who was now: not. "Because we're not licensing. We're not partnering. This formula was developed at IISc, with public research funding, by a team that includes: me. I'm seventeen. I can't sign a licensing agreement with a company worth forty-two thousand crores. And even if I could — I: wouldn't."

"May I ask: why?"

"Because your company sells: Fair & Glow. Your flagship product. A fairness cream that has been telling Indian women for thirty years that dark skin is: a problem. Your entire business model is built on: making people feel inadequate. And this formula does: the opposite. This formula makes people feel: whole. Why would I give a weapon of: liberation to a company that profits from: shame?"

The lab was: silent. The silence of a seventeen-year-old girl who had just told a forty-two-thousand-crore company to: leave.

Vikram Malhotra stood. Adjusted his suit. Smiled — the specific smile of a man who had been: declined before and who knew that: decline was: temporary.

"Think about it," he said. "The offer stands."

He left.

*

AJ saw what the humans in the room could not: see.

Vikram Malhotra's light was: absent. Not dim — absent. The specific absence that indicated a human who was not operating on: their own volition. A human who was: being whispered to. A human whose decisions were: not entirely their own.

"He's controlled," AJ said to Sid. "The Rakshas are using him."

"Using him: how?"

"The way they always use humans. By finding someone whose self-interest aligns with: their agenda and then: amplifying. Malhotra wants the formula because it's: profitable. The Rakshas want the formula because it's: dangerous — to them. If Zenith acquires the formula, the Rakshas can control how it's distributed. They can modify it. Add: a dependency. Make the injection temporary instead of permanent. Make humans need: repeated doses. Turn liberation into: addiction."

"Like the beauty industry already: works," said Sid.

"Exactly like the beauty industry already works. The Rakshas didn't create the beauty industry — they: shaped it. They ensured that every beauty product required: repurchase. That every solution was: temporary. That the cycle of inadequacy and temporary fix and: return to inadequacy would: continue forever. And now they want to do the same thing to: the formula."

"But Harini said: no."

"Harini said no. Today. But the Rakshas won't: stop. They'll find another way. A different pressure point. They always: do."

*

The pressure came from: three directions.

First: regulatory. The CDSCO — Central Drugs Standard Control Organisation — sent a notice to Dr. Subramaniam requesting that all trials be halted pending a "safety review." The notice was: standard procedure. But the timing was: suspicious. The notice arrived three days after Harini rejected Zenith's offer. And the CDSCO official who signed the notice was: married to Zenith's head of regulatory affairs.

"Coincidence," said Dr. Subramaniam. With the tone that meant: not coincidence.

Second: academic. A paper appeared in the Indian Journal of Cosmetic Dermatology — a paper authored by three professors at AIIMS Delhi — challenging the theoretical basis of golden-ratio facial restructuring. The paper argued that phi-based proportional adjustment was "mathematically unsound" and "biologically implausible." The paper cited: zero data. Because there was zero data: against the formula.

"They're manufacturing doubt," said Harini. Reading the paper at 2 AM in her Pune hostel room, the equations illuminated by the blue light of her: laptop. "This paper is: garbage. The mathematical analysis is: wrong. I can disprove every claim in: ten minutes."

"They don't need the paper to be: right," said Jai. On the phone from Bengaluru where he was managing the regulatory crisis. "They need the paper to: exist. So that when journalists write about the formula, they can quote 'concerns raised by AIIMS professors.' The doubt doesn't need to be: real. It needs to be: visible."

Third: personal. Harini's mother — who had been silent about her daughter's research, who had maintained the specific silence of a woman whose husband disappeared and who did not want to think about: why — called Harini.

"Harini, I'm asking you to: stop."

"Stop: what, Amma?"

"The formula. The injection. All of it. Your father — " The pause. The pause that contained: everything Harini's mother had never said about the night Meera Raj didn't come home. "Your father was researching: the same thing. And he: disappeared. Do you understand what I'm telling you? The same research. And he: disappeared."

"I know, Amma."

"You: know? You know and you're still — Harini, beta, I already lost: your father. I cannot lose: you."

The phone call. The 2 AM phone call from a mother who had been: silent for years and who was now: speaking because her daughter was walking the same path that had: swallowed her husband. The specific fear that transcended: logic. The fear that said: I don't care if the formula works. I don't care if it saves the world. I care if it takes: my daughter.

Harini held the phone. The blue light of the laptop. The paper that she could disprove in ten minutes. The regulatory notice that was blocking their trials. The corporate offer that she had: rejected. And now: her mother's voice. Asking her to: stop.

"Amma," Harini said. "Papa didn't disappear because the formula was: dangerous. He disappeared because it was: important. And I am: not stopping."

She hung up. Not cruelly — gently. The specific gentleness of a daughter who loved her mother and who was: choosing the formula anyway. The choice that would: haunt her. Because every choice that mattered: did.